GSK terminates collaboration with Alector after trial failures
Go back to GSK terminates collaboration with Alector after trial failures| (NASDAQ: ALEC) | Delayed: 2.47 +0.01 (0.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.46 | 52 Week High | $ | |||
| Open | $2.38 | 52 Week Low | $ | |||
| Day High | $2.61 | P/E | N/A | |||
| Day Low | $2.33 | EPS | $ | |||
| Volume | 916,105 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 48.54 -1.35 (2.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.89 | 52 Week High | $45.58 | |||
| Open | $49.00 | 52 Week Low | $37.82 | |||
| Day High | $49.23 | P/E | N/A | |||
| Day Low | $48.54 | EPS | $0.00 | |||
| Volume | 3,062,278 | |||||
